-
Regional Committee for Europe Sixtieth session
Moscow, 13–16 September 2010
Provisional agenda item 7(e) EUR/RC60/7 Rev.1 Add.3
1 September 2010 102187
ORIGINAL: ENGLISH
Membership of WHO bodies and committees
World Health Assembly resolution 63.28 recommended the
establishment of the Consultative Expert Working Group (CEWG) on
Research and Development: Financing and Coordination (WHA 63.28 is
attached as Annex 1). By note verbale of 30 June 2010, the
Director-General invited Member States to submit nominations to the
CEWG to the respective Regional Director. The deadline for receipt
of nominations was subsequently extended to 30 August 2010, as
advised in the Regional Director’s letter of 23 August 2010. This
document contains the curricula vitae of candidates nominated by
the Governments of Armenia, Denmark, Finland, France, Germany,
Israel, Montenegro, Norway, Portugal, Republic of Moldova, Spain
and Switzerland. Additional material, where supplied by candidates,
is available from the Secretariat. The Regional Committee is
therefore requested to consider the nominations received and make a
recommendation of those candidates to be forwarded to the Director
General. As a first step, all the nominations recommended by the
Regional Committee will be included in a global roster. Drawing on
this roster, the Director-General will then propose the composition
of the CEWG to the 128th session of the Executive Board in January
2011. Following approval by the Executive Board of the members of
the CEWG, the Director-General will propose the holding of the
first meeting of the CEWG, which is expected to be held in the
first quarter of 2011.
WORLD HEALTH OR GANIZAT ION • R EGIONAL OFF ICE FOR EUROPE
Scherfigsvej 8, DK-2100 Copenhagen Ø, Denmark Telephone: +45 39 17
17 17 Fax: +45 39 17 18 18
Electronic mail: [email protected] World Wide Web address:
http://www.euro.who.int
-
EUR/RC60/7 Rev.1 Add.3 page 3
Terms of reference of the CEWG
The CEWG will:
(a) take forward the work of the Expert Working Group which
submitted its final report to the WHA in 2009;
(b) undertake further analysis of the proposals in the Expert
Working Group’s report, and in particular: (i) examine the
practical details of the four innovative sources of financing
proposed in the report of the Expert Working Group; (ii) review the
five promising proposals identified n the report of the Expert
Working Group; and (iii) further explore the six proposals that did
not meet the criteria applied by the Expert Working Group;
(c) consider additional submissions and proposals from Member
States, including those arising out of any regional and subregional
consultations, and from other stakeholders;
(d) in carrying out the actions in subparagraphs (b) and (c),
examine the appropriateness of various research and development
financing approaches and the feasibility of implementing these
approaches in each of the six WHO regions, with subregional
analysis, as appropriate;
(e) observe scientific integrity and avoid conflicts of interest
in its work;.
Composition
The recommendation to the Executive Board on the composition of
the CEWG will be based on regional representation according to the
composition of the Executive Board, gender balance and diversity of
experience.
Nominations
The following nominations were received at the Regional Office
by 30 August 2010 and curricula vitae in standard format are
contained in the following pages:
Armenia (Dr Ara Ter-Grigoryan) Denmark (Professor Flemming
Konradsen) Finland (Dr Meri Tuulikki Koivusalo) France (Dr Jean
Edmond Deregnaucourt) Germany (Ms Ursula Schaefer-Preuss) Israel
(Dr Benny Leshem) Montenegro (Ms Ruzica Milutinovic) Norway (Dr
John-Arne Røttingen) Portugal (Dr Isabel Carvalho-Oliveira)
Republic of Moldova (Professor Aurel Grossu) Spain (Dr Anto
Boqué)
(Dr Rodriguez Artalejo) Switzerland (Dr Paul Linus
Herrling).
-
EUR/RC60/7 Rev.1 Add.3 page 4 NOMINATION FOR MEMBERSHIP OF THE
CONSULTATIVE EXPERT WORKING GROUP
ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: ARMENIA
Family name TER-GRIGORYAN First/Other names Ara Male/Female Male
Date of birth 6 March 1953
Contact address (include mobile number and e-mail):
G. Hoysepyan St. 10,. Yerevan. 0047, Republic of Armenia. State
Health (Financing) Agency of the Ministry of Health of the Republic
of Armenia. Mobile: 0037499007006; e-mail: [email protected]
Field(s) of expertise:
Health policy, health planning and administration, health
financing and management, health reform
Professional education: relevant important qualifications
Year
Yerevan State Medical University, Internal Medicine Department
PhD (Medical Sciences) Moscow First Medical Academy named after
E.M. Sechenov.
Moscow, Russian Federation Postgraduate courses, study tours,
scientific research seminars on health policy, health
planning and administration. health financing and management.
health care system reforms
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Head of the State Health (Financing) Agency of the Ministry of
Health Member of the National Health Accounts Steering Committee
appointed by the Prime Minister,
Coordinator of the Working Group on National Health Accounts
National Counterpart on Health Financing component in Biennial
Collaborative Agreements(BCA) Member of the Specialized Scientific
Council on Public health and health organization of the Supreme
Certification Commission of Armenia
Contributions: Significant contribution to the field of research
and development: financing and coordination
Research on principles and mechanisms of health care system
organization, administration andfinancing and their integration
under market conditions.
Research and implementation related to the Basic Benefits
Package design and implementation,resource allocation, new provider
payment mechanisms in health system (case-based and per capita
financing, global budget in contracting, performance-based
financing), health service purchasing and contracting.
restructuring of health-care delivery systems and health-care
systems.
Research on national health accounts and sub-accounts in
Armenia. Research on introducing co-payments in Armenia
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Role of health economics in the financial-economic management of
the health care system National Health Accounts (NHA) to Improve
Health Policy in Armenia Models and Mechanisms of Economic
Relations between the Customer and Provider of Medical
CareApplication of modem models of health care organization and
financing in the Republic of Armenia The role of independent
financing body in the management of financial flows in health care
system
-
EUR/RC60/7 Rev.1 Add.3 page 5
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: DENMARK
Family name KONRADSEN First/Other names Flemming Male/Female
Male Date of birth 5 February 1965
Contact address (include mobile number and e-mail):
School of Global Health, Øster Farimagsgade 5, bygning 9, PO.
BOX 2099, 1014 Copenhagen K Telephone +45 60 10 16 61 E-mail:
[email protected]
Field(s) of expertise:
Public health and environmental health in low-income
countries
Professional education: relevant important qualifications
Year
BSc; Cand. Scient.; PhD with a focus on environmental health and
public health in low-income countries
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Department of International Health, Immunology and Microbiology,
University of Copenhagen, Denmark
Professor, International Environmental Health focusing on
research and training on vectorborne diseases, water supply and
sanitation, toxicology and health and climate change inlow and
middle income countries.
Jan 2008 topresent
Rollings School of Public Health, Emory University, Atlanta, USA
Fellow providing input to the curricula in environmental health,
research project
management and research methods through supervision of students
and courses. Facilitates links between University of Copenhagen and
Emory University in the field of global health
Aug 2007 topresent
Department of International Health, Immunology and Microbiology,
University of Copenhagen, Denmark
Deputy Head of Department and Study Director for the Masters of
International Health programme. Member, Scientific Advisory Board,
Integrated Programme for Malaria Control in sub-Saharan Africa
Jan 2007 topresent
Consultative Group for International Agricultural
Research/International Water Management Institute, Sri Lanka
Senior international health expert on secondment from the Danish
government to assist with the analysis, project completion and
handing over of environmental health research projects in Sri
Lanka, Vietnam, India and Ghana. Due to the Tsunami in Asia, time
was also allocated for relief efforts in December 2005
Jun 2004–Jul 2005
-
EUR/RC60/7 Rev.1 Add.3 page 6 DENMARK – Konradsen cont’d
Institute of Public Health, University of Copenhagen, Denmark
Associate Professor; from January 2006 Head, Section of
International Health; from 2002
member of the governing board for the Institute of Public
Health. Research focuses on environmental health issues of
relevance to low- and middle-income countries. In addition to
research tasks, responsible for development of the general
curriculum in International Health and related courses for the
students of Public Health Sciences. Further responsibility for
teaching and planning of the modules related to water supply and
sanitation, disease vector control and exercises in epidemiology at
the Masters of International Health Programme. Thesis supervisor of
students in Medicine, Public HealtSciences and Masters of
International Health. Provided teaching input to courses in
relation to water supply, sanitation, hygiene promotion and malaria
control at a number oDanish and European universities.
Oct 2000–Dec 2007
Contributions: Significant contribution to the field of research
and development: financing and coordination
Substantial research in public health, especially in the areas
of environmental health; water supply andsanitation; hygiene
promotion; acute pesticide poisoning; control of vector-borne
diseases; agriculture and human health; health and water resources
management, and malaria.
Contribution to establishment of School of Global Health in
Denmark
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Pesticide self-poisoning: thinking outside the box. Konradsen et
al., Lancet, 2007 Engineering and malaria control: learning from
the past 100 years. Konradsen et al., Acta Tropica,
2004 Reducing acute poisoning in developing countries – options
for restricting the availability of pesticides.
Konradsen et al., Toxicology, 2003 Cost of malaria control in
Sri Lanka. Konradsen et al., WHO Bulletin, 1999 Measuring the
economic cost of malaria to households in Sri Lanka. Konradsen et
al., American
Journal of Tropical Medicine and Hygiene, 1997 A full list of
publications can be found by following this link:
-
EUR/RC60/7 Rev.1 Add.3 page 7
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE
Member State making nomination: FINLAND Family name KOIVUSALO
First/Other names Meri Tuulikki Male/Female Female Date of birth 5
January 1964
Contact address (include mobile number and e-mail):
National Institute for Health and Welfare, PO Box 30, 00271
Helsinki, Finland Phone: +358405091565; email:
[email protected] or [email protected]
Field(s) of expertise:
International health policy, health systems organization and
financing, global health
Professional education: relevant important qualifications
Year
MD (University of Helsinki), MSc (London School of Hygiene and
Tropical Medicine), PhD (University of Helsinki)
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Senior Researcher, National Institute for Health and Welfare
Advisory work for Ministry of Social Affairs and Health and
Ministry of Foreign Affairs on health, health
policy and global health issues Member of WHO scientific
resource group on trade and health One of three editors of the
journal Global Social Policy 2005–2010 One of six expert evaluators
of the European Commission’s International Cooperation with
Developing
Countries (INCO-DC) programme on health systems
Contributions: Significant contribution to the field of research
and development: financing and coordination
Advisor to and member of the Finnish delegation to
Intergovernmental Working Group (IGWG) negotiationsin 2006 and
responsible for making the initial European Union background paper
on issues and stands
Expert in negotiations concerning the IGWG – Global Plan and
Strategy for Action on Public Health,Innovation and Intellectual
Property Rights
Academic contribution as part of an international project funded
by the United Kingdom Economic andSocial Research Council (ESRC) on
nongovernmental action to improve the access of the poor to
good-quality low-cost drugs, working papers currently available at
http://www.open.ac.uk/ikd/projects_lowcostdrugs.shtml
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Koivusalo M, Ollila E. Making a healthy world. Agencies, actors
and policies in international health.: London, Zed Books, 1997.
Mackintosh M, Koivusalo M (eds). Globalization and
commercialization in health: global and local trends and responses.
Basingstoke, Palgrave, 2005.
Koivusalo M. Trade and health – the ethics of global rights,
regulation and redistribution. In: Benatar S,Brock G (eds). Global
health ethics. Cambridge, Cambridge University Press (in
press).
Koivusalo M et al. Globalization and policy space for health and
social determinants of health. In: Labonte Ret al. (eds).
Globalization and health: Pathways, evidence and policy. New
York/London, Routledge, 2009.
Koivusalo M, Mackintosh M. Commercial influence and global
nongovernmental public action in health and pharmaceutical
policies. International Journal of Health Services (in press)
-
EUR/RC60/7 Rev.1 Add.3 page 8 NOMINATION FOR MEMBERSHIP OF THE
CONSULTATIVE EXPERT WORKING GROUP
ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: FRANCE
Family name DEREGNAUCOURT First/Other names Jean, Edmond
Male/Female Male Date of birth 22 May 1948
Contact address (include mobile number and e-mail):
Institut Pasteu 28 rue du Docteur Roux - 75724 Paris Cedex 15 –
France Tel.: 33 (0) 1.40.61.32.43; Fax: 33 (0) 1.40.61.36.96;
mobile: 33 (0) 6.29.37.31.97 E-mail :
[email protected]
Field(s) of expertise:
Research Development. Medicine registration. Support operations
for innovation in biotechnology and health. Wide experience of
international collaboration in English
Professional education: relevant important qualifications
Year
Doctor of veterinary medicine Certificate of Higher Studies in
Pharmacolgy Post doctoral, University of California at Los Angeles
(UCLA)
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Directory of Research applications and Industiral Relations,
Institut Pasteur 2010Delegate General, Medice Biocluster, Paris
Région 2009-2010Director of Biotechnogies, Ministry of Higher
Education and Research 2003-2006Chairman and Director of Research
and Development, Pierre Fabre Laboratories 1998-2003Vice-Chairman
of International Chemical and Pharmaceutical Development, Rhône
Poulenc Rorer (Aventis) 1994-1998
Contributions: Significant contribution to the field of research
and development: financing and coordination
Significant contributions to three activities relating to
financing and coordination of research and development: - initiated
appeal for the National Research Agency project on the emergence
and development ofhigh-potential projects;- was a major contributor
to the formation of the European Biotechnologies
networkEUROTRANSBIO - was a partner in the Advanced Bioclusters for
Europe network.
Vice-Chairman of the intergovernmental Franco-Chinese Committee
on the development of traditional Chinese medicine
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
-
EUR/RC60/7 Rev.1 Add.3 page 9
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: GERMANY
Family name SCHAEFER-PREUSS First/Other names Ursula Male/Female
Female Date of birth
Contact address (include mobile number and e-mail):
6 ADB Avenue, Mandaluyong City 1550, Philippines Tel: +63-2 632
5006; e-mail: [email protected]
Field(s) of expertise:
Economics, sociology, development policy
Professional education: relevant important qualifications
Year
Postgraduate studies in political science, economics and
sociology, major in developmentpolicy
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Vice President, Asian Development Bank (ADB)
2006–presentDirector General, Federal Ministry for Economics
Cooperation and Development
(Bundesministerium für Wirtschaftliche Zusammenarbeit (BMZ))
2000–2006
Chief of Cabinet of the Federal Ministry for Economics
Cooperation and Development (BMZ)
1998–2000
Head of Division, Latin America (East), Mexico and regional
development policy in Latin America (BM2)
1995–1998
Contributions: Significant contribution to the field of research
and development: financing and coordination
Responsible for ADB's Regional and Sustainable Development
Department and Economics andResearch. Member of the advisory board
of various research-oriented development institutes. Member of the
Genman Society for Foreign Policy. Author of publications on
development issues. Former member of the Expert Working Group.
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
-
EUR/RC60/7 Rev.1 Add.3 page 10 NOMINATION FOR MEMBERSHIP OF THE
CONSULTATIVE EXPERT WORKING GROUP
ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: ISRAEL
Family name LESHEM First/Other names Benny Male/Female Male Date
of birth 17 August 1946
Contact address (include mobile number and e-mail):
Director, Medical Research Administration, The Chief Scientist
Office Ministry of Health, 2, Ben-Tabai St., Jerusalem 91010,
Israel Tel: +972-2-568-1208; Fax: +972-2-672-5833; Mobile:
+972-50-624-2187 E-mail: [email protected]
Field(s) of expertise:
Immunology; Research Administration
Professional education: relevant important qualifications
Year
Ph.D. in Immunology 1979Higher courses in executive
administration
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Director, Medical Research Administration, the Chief Scientist
Office, Israeli Ministry of Health
1999-present
Board member in European Research Area Networks (ERA-Nets):
CoCanCPG, ERA-IB, ERA-Age, ERA-Age 2, ERA-Neuron, ERA-PathoGenoMics
(Chairperson 2009), EuroNanoMed (Vice-Chairperson 2009 to date)
2004-present
Researcher, Assistant Professor, Lautenberg Center for General
and Tumor Immunology, Hebrew University–Hadassah Medical School,
Jerusalem, Israel
1981-1999
Contributions: Significant contribution to the field of research
and development: financing and coordination
Set-up of an on-line research application system; Set-up of peer
review panels for applications; Funding of medical research
projects; Set-up of coordinated activities on "Science to Society";
Set-up of research relations with member countries of the European
Union (EU) and Canada; Coordination of multinational joint calls
for research applications.
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Bronstein-Sitton N et al. Sustained exposure to bacterial
antigen induces interferon-gamma-dependent T cell receptor zeta
down-regulation and impaired T cell function. Nat Immunol. 2003
Oct;4(10):957-64.
Fervers B et al. CoCanCPG. Coordination of cancer clinical
practice in Europe. Tumori, 2008, 94(2): 154-159.
Golenser J et al. Iron chelators: correlation between effects on
Plasmodium spp. and immune functions., J Parasitol. 2006
Feb;92(1):170-7.
Leshem B, Rager B. Chief Scientist Research Grants, Israeli
Medical Encyclopedia, 2007, 9: 2132
-
EUR/RC60/7 Rev.1 Add.3 page 11
ISRAEL – Leshem cont’d Leshem B et al. Correlation between
enhancement of graft-versus-leukemia effects following
allogeneic bone marrow transplantation by rIL-2 and increased
frequency of cytotoxic T-lymphocyte precursors in murine myeloid
leukemia. Cytokines Cell Mol Ther. 2000 Sep;6(3):141-7.
Leshem B et al. Induction of preferential cytotoxicity against
allogeneic mouse lymphoma cells: in vitro and in vivo studies.
Cancer Immunol Immunother. 1999 Jul;48(4):179-88.
Rager B, Leshem B. Chief Scientist at the Israeli Ministry of
health, Israeli Medical Encyclopedia, 2007, 9: 2126
Rager B et al. Medical research in Israel: future challenges.
Isr Med Assoc J. 2000 Jul;2 Suppl:2-4.
-
EUR/RC60/7 Rev.1 Add.3 page 12 NOMINATION FOR MEMBERSHIP OF THE
CONSULTATIVE EXPERT WORKING GROUP
ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: MONTENEGRO
Family name MILUTINOVIC First/Other names Ruzica Male/Female
Female Date of birth 16 October 1974
Contact address (include mobile number and e-mail):
+382 67514316 [email protected]
Field(s) of expertise:
Financing and coordination
Professional education: relevant important qualifications
Year
Master’s Degree in Actuarial Science 2007Podgorica School of
Economics, University of Montenegro – Bachelor’s Degree, Major
in
Management 2000
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Montenegro National Health Insurance Fund. Head of the
department for monitoring the collection of compulsory health
insurance contributions and making national health insurance
accounts
Nov 2006 to present
Montenegro National Health Insurance Fund. Head of the
department for maintaining records of insured beneficiaries
Jan 2003–Nov 2006
Contributions: Significant contribution to the field of research
and development: financing and coordination
World Bank – Local consultant under technical assistance in the
design and production of nationalhealth accounts
Team member for the Ministry of Finance project on “Unified
registration and collection of taxes and contributions”
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Kašćelan V, Milutinović R. Health insurance market in
Montenegro. Accounting and Audit, 3 (2008). Milutinović R. Analysis
of material and financial expenditure on medications that are
prescribed and
issued at the expense of the Health Insurance Fund for the
period 2006-2008 (2008) Milutinović R. Analysis of tender prices of
medications for the period 2005-2008 (2008) Milutinović R. Analysis
of the consumption of medications and medical devices issued at the
expense
of the National Health Insurance Fund in pharmacy institutions
of Montenegro in 2007 (2008) Milutinović R. Analysis of the
consumption of medications and medical devices issued at the
expense
of the National Health Insurance Fund in pharmacy institutions
of Montenegro in 2006 (2007)
-
EUR/RC60/7 Rev.1 Add.3 page 13
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: NORWAY
Family name RØTTINGEN First/Other names John-Arne Male/Female
Male Date of birth 27 March 1969
Contact address (include mobile number and e-mail):
Norwegian Knowledge Centre for the Health Services PO Box 7004
St Olavs plass, N-0130 Oslo Norway Mobile: +4795980589; e-mail:
[email protected]
Field(s) of expertise:
Biomedicine, Infectious disease epidemiology, health services
research, health technology assessment, research policy
Professional education: relevant important qualifications
Year
MSc (Distinction) in Epidemiology, Evolution and Control of
Infectious Disease, Wellcome Trust Centre for the Epidemiology of
Infectious Disease, Department of Zoology, University of Oxford
2000
PhD; Faculty of Medicine and The Biotechnology Centre of Oslo,
University of Oslo 1999Authorized clinical medical doctor in Norway
1998MD, Faculty of Medicine, University of Oslo 1996
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Adjunct Professor in Health Policy at the Department of Health
Management and Health Economics, Institute of Health and Society,
Faculty of Medicine, University of Oslo
Jan 2010–present
Chief executive/Director-General, Norwegian Knowledge Centre for
the Health Services
Feb 2004–present
Associate Professor, Head of Medical Research Curriculum,
thematic leader, Centre for the Prevention of Global Infections,
Faculty of Medicine, University of Oslo
Jul 2002–Jan 2004
Research coordinator, Department of Infectious Disease
Epidemiology, Division for Infectious Disease Control, Norwegian
Institute of Public Health
Mar 2002–Jan 2004
Contributions: Significant contribution to the field of research
and development: financing and coordination
Board member and now Chair of the Alliance for Health Policy and
Systems Research Chief delegate of the Norwegian delegation on the
Intergovernmental Working Group on Public
Health, Innovation and Intellectual Property, WHO Participant in
meeting on Collaborative arrangements for global health research
May 11 2009 Supervising PhD student on Open source drug discovery
as a mechanism for innovation of drugs for
neglected diseases
-
EUR/RC60/7 Rev.1 Add.3 page 14 NORWAY – Røttingen cont’d
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Frønsdal KB, Facey K, Klemp M, Norderhaug IN, Merland B,
Røttingen JA Health technology assessment to optimize health
technology utilization: using implementation initiatives and
monitoringprocesses. International Journal of Technology Assessment
in Health Care. 2010; 26:309-16.
Velasco Garrido M, Gerhardus A, Røttingen JA, Busse R.
Developing Health Technology Assessment to address health care
system needs. Health Policy. 2010; 94:196-202. Epub 2009 3 Nov.
Røttingen JA, Buss PM, Davies S, Toure O. Global health-
research architecture: time for mergers? Lancet 2009; 373:
193-5.
Guerin PJ, Næss LM, Fogg C, Rosenqvist E, Pinoges L, Bajunirwe
F, Nabasumba C, Borrow R,Frøholm Lo, Ghabri SG, Batwala V, Twesigye
R, Aaberge IS, Røttingen JA, Piola P, Caugant DA Immunogenicity of
Fractional Doses of Tetravalent A/C/Y!W135 Meningococcal
PolysaccharideVaccine: results from a randomised non-inferiority
controlled trial in Uganda. Public Library of Science Neglected
Tropical Diseases. 2008; 2: e342.
Olliaro PJ, Guerin Pl, Gerstl S, Haaskjold AA, Røttingen JA,
Sundar S. Treatment options for visceral leishmaniasis: a
systematic review of clinical studies done in India, 1980-2004.
Lancet InfectiousDiseases 2005; 5: 763-74.
-
EUR/RC60/7 Rev.1 Add.3 page 15
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: PORTUGAL
Family name CARVALHO-OLIVEIRA First/Other names Isabel
Male/Female Female Date of birth 27 February 1978
Contact address (include mobile number and e-mail):
Field(s) of expertise:
Research management; proteomies
Professional education: relevant important qualifications
Year
PhD in Biology (Molecular Biology) from the Faculty of Science,
University of Lisbon, summa cum laude
2008
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Coordinator of the Research Management Office at the Nacional de
Saude Instituto Dr Ricardo Jorge
Jan 2009–present
PhD student at Erasmus University, The Netherlands and the
Nacional de Saude Instituto Dr Ricardo Jorge
Contributions: Significant contribution to the field of research
and development: financing and coordination
Involved in the coordination of the Portuguese Roadmap for
Health Research Establishment of the Research Management Office at
Instituto Nacional de Saude Dr Ricardo Jorge, which provides for
research and development projects financial follow-up designs
strategies for monitoring, evaluates such projects and provides
subsequent financial support.
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Carvalho-Oliveira IM, Charro N, Aarbiou J, Buijs-Offerman RM,
Wilke M, Schettgen T, Kraus T, Titulaer MK, Burgers P, Luider TM,
Penque D, Scholte BJ (2009), "Proteomic analysis
ofnaphthalene-induced airway epithelial injury and repair in a
cystic fibrosis mouse model" Journal of Proteome Research,
Jul;8(7):3606-16.
Oleastro M, Cordeiro R, Ferrand J, Nunes E, Lehours P,
Carvalho-Oliveira I, Mendes AI, Penque D, Monteiro L, Mégraud F,
Ménard A (2008), "Evaluation of the clinical significance of homB,
a novel candidate marker of Helicobacter pylori strains associated
with peptic ulcer disease." Journal of Infectious Diseases, Nov
1;198(9):1379-87.
Carvalho-Olivcira I, Scholte BJ, Penque D. (2007), "What have we
learned from mouse models forcystic fibrosis?", Expert Review of
Molecular Diagnostics, Jul;7(4):407-17. Review.
Harris CM, Mendes F, Dragomir A, Doull JJ, Carvalho-Olivcira I,
Bebok Z, Clancy JP, Eubanks V, Sorscher EJ, Roomans GM, Amaral MD,
McPherson MA, Penque D, Dormer RI. (2004),"Assessment of CFTR
localisation in native airway epithelial cells obtained by nasal
brushing", Journal of Cystic Fibrosis., Aug;3 SuppI 2:43-8.
Review.
Carvalho-Oliveira I, Efthyrniadou A, Malhó R, Nogueira P, Tzetis
M, Kanavakis E, Amaral MD, PenqueD. "CFTR localization in native
airway cells and cell lines expressing wild-type or F508del-CFTR by
a panel of different antibodies.", Journal of Histochemistry and
Cytochemistry. 2004 Feb;52(2):193-203
-
EUR/RC60/7 Rev.1 Add.3 page 16 NOMINATION FOR MEMBERSHIP OF THE
CONSULTATIVE EXPERT WORKING GROUP
ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: REPUBLIC OF
MOLDOVA
Family name GROSSU First/Other names Aurel Male/Female Male Date
of birth 6 February 1949
Contact address (include mobile number and e-mail):
ul. Lapushneanu 4/1 2004 Chisinau, Moldova Tel: 003732 256102;
Fax: 00372 723620; mobile: (0) 799 56957 E-mail:
[email protected]
Field(s) of expertise:
Cardiology
Professional education: relevant important qualifications
Year
Postgraduate studies at the All-Union Cardiology Research
Centre, Moscow 1981–1984Qualification in cardiology, St.
Petersburg, Russian Federation 1979Graduate of the State Medical
Institute, Chisinau 1972
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Deputy Director for Research, Institute of Cardiology 1998 to
presentSuccessively (Researcher, Senior Researcher, Director)
Urgent Cardiology Clinic 1984–1998Chairman of the Ministry of
Health Council of Experts Chairman of the Ministry of Health
Commission on Cardiology and Rheumatology
Contributions: Significant contribution to the field of research
and development: financing and coordination
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Aritmiile cardiace. Diagnosticare si tratament Monografie,
Chisinau, 1999, Firma Editorial Poligrafica, “Tipografia Centrala”
(in Romanian)
Long-term prognosis in diabetic patients with acute coronary
syndrome, Journal of Coronary ArteryDisease, Istanbul, Turkey,
2005
Metabolic Treatment with L-Carnitine in Acute Anterior ST
Segment Elevation Myocardial Infarction. A Randomized Controlled
Trial, CEDIM 2 Study Organization. Cardiology 2006; 106:215–223.
With G. Tarantinia, D. Scrutiniob, P. Bruzzic, L. Bonic, P.
Rizzond, Sabino Ilicetoa
Clinical and paraclinical characteristics of patients with
ischemic stroke and atrial fibrillation. International Journal of
Stroke vol. 3, supplement 1, 2008, PO 01–30, Abstracts of the 6th
World Stroke Congress and Xth International Sympozium of
Thrombolysis and Acute Stroke Therapy
Sincopa, diagnosicare si tratament. Monografie. Editura
Universul, Chisinau, 2009 (in Romanian)
-
EUR/RC60/7 Rev.1 Add.3 page 17
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: SPAIN
Family name ANTÓ BOQUÉ First/Other names Josep M. Male/Female
Male Date of birth 17 August 1952
Contact address (include mobile number and e-mail):
CENTRO de Investigacion en Epidemjologia Ambiental (CREAL) Parc
de Recerca Biomedica de Barcelona (Despatx 195) Doctor Aiguader 88,
08003 Barcelona Tel. +34932147360; mobile: 6499270241; Fax +34
932147302; e-mail: [email protected] www.creal.cat
Field(s) of expertise:
Epidemiology and public health. Epidemiology of asthma and
chronic obstructive pulmonary disease
Professional education: relevant important qualifications
Year
Doctor of medicine and surgery, Autonomous University of
Barcelona 1990Specialist in internal medicine, Autonomous
University of Barcelona 1981Specialist in respiratory medicine,
Autonomous University of Barcelona 1981Graduated in medicine and
surgery, Autonomous University of Barcelona 1975
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Director, Centre for Research in Environmental Epidemiology
(CREAL) Dec 2005 to presentProfessor of Medicine, Department of
Experimental Sciences and Health,
Pompeu Fabra University. Apr 2001 to present
Director, Centre Network for Biomedical Research and Public
health 2007-2010Director, Municipal Institute of Medical Research
2005-2006Vice-Chancellor for Science Policy, Pompeu Fabra
University 2001-2003
Contributions: Significant contribution to the field of research
and development: financing and coordination
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Kogevinas M, Antó, JM, Sunyer J, Tobias A, Kromhout H, Burney P,
and the European Community Respiratory Health Survey Study Group.
Occupational asthma in Europe and other industrialisedareas: a
population-based study. Lancet 1999; 353: 1750-1754
Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana
E, Radon K, Toren K, Alliksoo A,Benke G, Blanc PD, Dahlman-Hoglund
A, D'Errico A, Hery M, Kennedy S, Kunzli N, Leynaert B, Mirabelli
MC, Muniozguren N, Norback 0, Olivieri M, Payo F, Villani S, van
Sprundel M, Urrutia I,Wieslander G, Sunyer J, Antó JM. Exposure to
substances in the workplace and new-onset asthma: an international
prospective population-based study (ECRHS-II). Lancet 2007; 370;
336–341
Delelos Gl, Gimeno 0, Arif M, Burau KD, Carson A, Lusk C, Stock
T, Symanski E, Whitehead LW, Zock JP, Benavides FG, Antó JM.
Occupational risk factors and asthma among health care
professionals. American Journal of Respiratory and Critical Care
Medicine. 2007 Apr 1;175(7):667–675
-
EUR/RC60/7 Rev.1 Add.3 page 18 SPAIN – Antó Boqué cont’d
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular
physical activity modifies
smoking-related lung function decline and reduces risk of
chronic obstructive pulmonary disease: apopulation-based cohort
study. American Journal of Respiratory and Critical Care Medicine.
2007 Mar 1;175(5):458–463
Puhan MA, Garda-Aymerich J, Frey M, ter Riet G, Antó JM, Agusti
AG, Gomez FP, Rodriguez-Roisin R, Moons KG, Kessels AG, Held U.
Expansion of the prognostic assessment of patients with chronic
obstructive pulmonary disease: the updated BODE index and the ADO
index. Lancet. 2009 Aug29;374(9691 ):704–711
-
EUR/RC60/7 Rev.1 Add.3 page 19
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: SPAIN
Family name RODRÍGUEZ ARTALEJO First/Other names Fernando
Male/Female Male Date of birth
Contact address (include mobile number and e-mail):
[email protected]
Field(s) of expertise:
Preventive Medicine and Public Health
Professional education : relevant important qualifications
Year
Specialist in Preventive Medicine and Public Health, vfa MIR. La
Paz Hospital 1987Doctor of Medicine, Department of Preventive
Medicine and Public Health, Autonomous
University of Madrid 1986
Master in Public Health 1985Graduate in medicine, Autonomous
University of Madrid 1983
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Professor of Preventive Medicine and Public Health. Autonomous
University of Madrid
2000 to present
Professor of Preventive Medicine and Public Health. University
of the Basque Country
1995–2000
Head of Environmental Risk Assessment Unit, Directorate-General
of Public Health
Various posts in Ministry of Health and Consumer Affairs
1987–1991
Contributions: Significant contribution to the field of research
and development: financing and coordination
Supervisor of 25 doctoral dissertations, three of which received
Premio Extraordinario del Doctorado Author or co-author of over 100
articles in scientific and professional journals
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Royo-Bordonada MA, Gorgojo L, de Oya M, Garcés C,
Rodríguez-Artalejo F, Rubio R, del Barrio JL, Martin~Moreno JM.
Dietary variety and diversity of Spanish children: Four Provinces
Study. [Article in Spanish] Medicina Clinica (Barcelona). 2003 Feb
15;120(5):167-71
Rodríguez-Artalejo F, Guallar E, Borghi C, Dallongeville J, De
Backer G, Harcox JP, Hernandez-Veclno R. Jiménez FJ. Massó-Gonzáléz
EL, Perk J, Steg PG, Banegas JR; EURIKA Investigators. Rationale
arid methods of the European study on Cardiovascular Risk
Prevention and Managementin Dally Practice (EURlKA). BMC Public
Health. 2010 Jun 30;10:382
Oliveira A, Lopes C, Rodríguez-Artalejo F. Adherence to the
Southern European Atlantic Diet and occurrence of nonfatal acute
myocardial Infarction. American Journal of Clinical Nutrition. 2010
Jul;92(1):211~7. Epub 2010 May 19
Regidor E, Guallar-Castillón P, Gutiérrez-Fisac JL, Banegas JR,
Rodríguez-Artalejo F. Socioeconomic variation in the magnitude of
the association between self-rated health and mortality. Annals of
Epidemiology. 2010 May;20(5):395-400
-
EUR/RC60/7 Rev.1 Add.3 page 20 SPAIN – Rodríguez Artalejo cont’d
Romero-Fernandez MM. Royo-Bordonada MA, Rodriguez-Arialejo F.
Compliance with self-regulation
of television food and beverage advertising aimed at children in
Spain. Public Health Nutrition. 2010 Jul; 13(7):1013-21. Epub 2009
Nov 16
-
EUR/RC60/7 Rev.1 Add.3 page 21
NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING
GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION
CURRICULUM VITAE Member State making nomination: SWITZERLAND
Family name HERRLING First/Other names Paul Linus Male/Female
Male Date of birth 16 December 1946
Contact address (include mobile number and e-mail):
Novartis Pharma AG, WSJ-200.204, Postfach, 4002 Basel Tel: 061
324 62 84; Fax: 061 324 21 41; mobile: 079 321 30 09 Email:
[email protected]
Field(s) of expertise:
Research
Professional education: relevant important qualifications
Year
Doctorate, University of Zurich Post-doctorate studies at
Neuropsychiatry Institute, University of California at Los
Angeles
Professional career: list current post first, followed by up to
four most important positions held Year (start/end)
Head of Novartis Institutes for Developing World Medical
Research at Novartis Pharma AG
Head of Corporate Research at Novartis International AG Head of
Global Research at Novartis Pharma AG Head of Preclinical Research
Basel Sandoz Pharma AG
Contributions: Significant contribution to the field of research
and development: financing and coordination
Chairman of the Board of Directors of the Novartis Institute for
Tropical Diseases Member of the Scientific Advisory Committee of
the Drugs for Neglected Diseases Initiative
Publications: List five significant publications relevant to
biomedical research and development: financing and coordination
Herrling PL. Financing R&D for neglected diseases. Nat Rev
Drug Discov. 2009 Feb;8(2):91. Pogacić Kramp V, Herrling P. List of
drugs in development for neurodegenerative diseases: update
June 2009. Neurodegener Dis. 2009;6(4):165-212. Epub 2009 Aug 8.
Herrling P. Patent sense. Nature. 2007 Sep 13;449(7159):174-5.
Herrling P. [First success of research. Soon a drug against dengue
fever?]. MMW Fortschr Med. 2007
Apr 19;149(16):12. German. Herrling P. Experiments in social
responsibility. Nature. 2006 Jan 19;439(7074):267-8.
Terms of reference of the CEWGCompositionNominations